Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 2/20 | 0.52 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.41 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1478687 | 0.72 | GPR3 (0.44) | GPR3SLC22A2SLC22A3KMT2AHTR2A | |
| SCHEMBL1509312 | 0.69 | GPR3 (1.00) | GPR3SLC22A2SLC22A3KMT2AHTR2A | |
| SCHEMBL1044055 | 0.69 | GPR3 (0.41) | GPR3KMT2AHTR2APOLBACHE | |
| SCHEMBL27462668 | 0.69 | GPR3 (0.41) | GPR3SLC22A2SLC22A3KMT2AHTR2A | |
| SCHEMBL16632987 | 0.69 | GPR3 (0.41) | GPR3KMT2AHTR2APOLBMEN1 | |
| SCHEMBL29953549 | 0.69 | GPR3 (0.41) | GPR3KMT2AHTR2APOLBACHE | |
| SCHEMBL28709520 | 0.67 | GPR3 (0.95) | GPR3SLC22A2SLC22A3KMT2AHTR2A | |
| SCHEMBL6428369 | 0.66 | KMT2A (0.40) | GPR3SLC22A2SLC22A3KMT2AHTR2A | |
| SCHEMBL6428815 | 0.66 | GPR3 (0.39) | GPR3SLC22A2SLC22A3KMT2AHTR2A | |
| SCHEMBL29290193 | 0.65 | GPR3 (0.67) | GPR3SLC22A2SLC22A3KMT2AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6891005-B2 | Bridged metal complexes for gas phase polymerizations | BP CHEMICALS LIMITED (GB) | 2005-05-10 | — | — | US | disclosed |
| US-20040010102-A1 | Bridged ylide group containning metal complexes | ROBERT BOSCH GMBH (DE) | 2004-01-15 | — | — | US | disclosed |
| US-20030199650-A1 | Bridged metal complexes for gas phase polymerizations | BP CHEMICALS LIMITED | 2003-10-23 | — | — | US | disclosed |
| EP-1119575-B1 | BRIDGED METAL COMPLEXES | DOW CHEMICAL CO (US) | 2003-09-03 | — | — | EP | disclosed |
| EP-1328533-A1 | BRIDGED YLIDE GROUP CONTAINING METAL COMPLEXES | Dow Global Technologies Inc. (US) | 2003-07-23 | — | — | EP | disclosed |
| US-6500949-B2 | ALPHA-OLEFIN POLYMERIZATION CATALYST | DOW GLOBAL TECHNOLOGIES INC. | 2002-12-31 | — | — | US | disclosed |
| EP-1141034-B1 | BRIDGED METAL COMPLEXES FOR GAS PHASE POLYMERIZATIONS | BP CHEM INT LTD (GB) | 2002-10-30 | — | — | EP | disclosed |
| US-20020098973-A1 | Bridged gallium or indium containing group 4 metal complexes | CAMPBELL RICHARD E (US) | 2002-07-25 | — | — | US | disclosed |
| WO-2002034759-A1 | BRIDGED YLIDE GROUP CONTAINING METAL COMPLEXES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2002-05-02 | — | — | WO | disclosed |
| US-6376406-B1 | COORDINATION POLYMERIZATION CATALYSTS FOR ALPHA-OLEFINS | THE DOW CHEMICAL COMPANY | 2002-04-23 | — | — | US | disclosed |
| US-20010025115-A1 | Bridged metal complexes | DOW GLOBAL TECHNOLOGIES LLC | 2001-09-27 | — | — | US | disclosed |
| US-6284905-B1 | GROUP 4 TRANSITION METAL COMPLEX CONTAINING A BORON OR ALUMINUM BRIDGING GROUP CONTAINING A NITROGEN CONTAINING ELECTRON DONATING GROUP, ESPECIALLY AN AMIDO GROUP; OLEFIN SOLUTION OR SLURRY POLYMERIZATION CATALYSTS | THE DOW CHEMICAL COMPANY | 2001-09-04 | — | — | US | disclosed |
| WO-2001058912-A1 | DINUCLEAR GROUP 4 METAL BORON OR ALUMINUM BRIDGE CONTAINING ANSA-COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-08-16 | — | — | WO | disclosed |
| WO-2001046201-A1 | GALLIUM OR INDIUM-BRIDGED GROUP 4 METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010025115-A1 | Bridged metal complexes | SLC39A14, NBAS, MCM4 | GPR3 4478/4885SLC22A2 2702/4885SLC22A3 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.